scholarly journals Patient Blood Management in Europe: surveys on top indications for red blood cell use and Patient Blood Management organization and activities in seven European university hospitals

Vox Sanguinis ◽  
2016 ◽  
Vol 111 (4) ◽  
pp. 391-398 ◽  
Author(s):  
M. T. Bruun ◽  
K. Pendry ◽  
J. Georgsen ◽  
P. Manzini ◽  
M. Lorenzi ◽  
...  
Keyword(s):  
Blood Cell ◽  
Red Blood Cell ◽  
Patient Blood Management ◽  
Blood Management ◽  
University Hospitals ◽  
Management Organization ◽  
European University

scholarly journals A SARS-CoV-2-pandémia hatása a vérkészítmény-felhasználásra a Pécsi Tudományegyetemen

2021 ◽  
Vol 162 (43) ◽  
pp. 1717-1723
Author(s):  
Sándor Pál ◽  
Barbara Réger ◽  
Tamás Kiss ◽  
Hussain Alizadeh ◽  
András Vereczkei ◽  
...  
Keyword(s):  
Blood Transfusion ◽  
Blood Cell ◽  
Red Blood Cell ◽  
Blood Product ◽  
Patient Blood Management ◽  
Blood Products ◽  
Blood Management ◽  
Number Of Patients ◽  
Willingness To Donate ◽  
The Impact

Összefoglaló. Bevezetés: A COVID–19-világjárvány betegellátásra gyakorolt hatása hazánkban is jelentős. A vérellátást nehezítette a járványügyi intézkedések következményeként a véradási események elmaradása, a csökkent véradási hajlandóság, továbbá a nehezen megítélhető vérkészítményigény . A „Patient Blood Management” irányelveinek az orvosi gyakorlatban történő egyre szélesebb körű alkalmazása elősegíti az optimális vérkészítmény-felhasználást a transzfúziók lehetőség szerinti elkerülésével. Célkitűzés és módszer: Vizsgálatunk célja a Pécsi Tudományegyetem Klinikai Központjának Janus Pannonius Klinikai Tömbjében a vérkészítmény-felhasználás változásainak felmérése volt a 2020. év első öt hónapjában. Eredmények: A járványügyi intézkedéseket követő időszakban szignifikánsan csökkent a hospitalizált betegeknek (34,08%), a transzfúziót igénylő betegeknek (39,69%) és a felhasznált vörösvérsejt-készítményeknek (46,41%) a száma, valamint az egy betegre jutó felhasznált vörösvérsejt-koncentrátum átlaga (2,61-ről 1,97-re) is. Közel 30%-os arányban csökkent a felhasznált friss fagyasztott plazma egységeinek és a thrombocytakoncentrátumoknak a száma is. Következtetés: A szigorú korlátozások életbe léptetését követően a nehézségek ellenére sikerült elegendő mennyiségű vérkészítményt biztosítani a betegeknek. Az Országos Vérellátó Szolgálat Pécsi Regionális Vérellátó Központja munkatársainak és a klinikusok erőfeszítéseinek köszönhetően a vérkészítményigény és -kínálat között új egyensúly alakult ki, mely megfelelő ellátást biztosított a feltétlenül szükséges transzfúziók kivitelezéséhez. Orv Hetil. 2021; 162(43): 1717–1723. Summary. Introduction: The impact of COVID–19 pandemic on patient care is pronounced also in Hungary. Blood supply was hindered by the reduction of public blood donation events, the reduced willingness to donate, and the difficult predictability of blood product demand as a result of the epidemiological regulations. The wider application of Patient Blood Management guidelines in the medical practice will promote optimal blood product utilization by avoiding transfusions where possible. Objective and method: The aim of our study was to assess the changes in the usage of blood products in the first five months of 2020 at the Clinical Center of the University of Pécs, Janus Pannonius Clinical Building. Results: In the period following the epidemiological measures, we found reduction in the number of hospitalized patients (34.08%), in the number of patients requiring transfusion (39.69%) and in the number of red blood cell products used (46.41%). The number of transfused red blood cell concentrates per patient was also significantly reduced (from 2.61 to 1.97) in this period. The number of transfused fresh frozen plasma units and platelet concentrates also decreased by approximately 30%. Conclusion: After the implementation of the strict restrictions, despite the difficulties, it was possible to provide patients with sufficient blood products. Due to the efforts of both the Regional Blood Transfusion Center of Pécs of the Hungarian National Blood Transfusion Service and of the clinicians, a new balance was established between the demand and the supply of blood products, which provided adequate care for the necessary transfusions. Orv Hetil. 2021; 162(43): 1717–1723.

Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study

Transfusion ◽  
2016 ◽  
Vol 56 (8) ◽  
pp. 1965-1973 ◽  
Author(s):  
Mark H. Yazer ◽  
Bryon Jackson ◽  
Neil Beckman ◽  
Stuart Chesneau ◽  
Patrick Bowler ◽  
...  
Keyword(s):  
Blood Cell ◽  
Red Blood Cell ◽  
Patient Blood Management ◽  
Blood Management ◽  
Blood Center

scholarly journals Patient Blood Management: Implementation of a Preoperative Anemia Clinic for Elective Orthopedic Surgical Patients

Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 2547-2547
Author(s):  
Paul Letendre ◽  
Emily Coberly ◽  
Katie Dettenwanger ◽  
Kan Huang
Keyword(s):  
Patient Safety ◽  
Blood Cell ◽  
Red Blood Cell ◽  
Elective Surgery ◽  
Surgical Patients ◽  
Patient Blood Management ◽  
Blood Management ◽  
Preoperative Anemia ◽  
Red Blood Cell Transfusions ◽  
Work Up

Abstract Background: Patient blood management (PBM) programs aim to implement best practices and encourage blood stewardship. Judicious use of red blood cell transfusions improves patient safety, decreases hospital length of stay (LOS) and reduces cost. A 2010 World Health Organization statement asserted "…before surgery every reasonable measure should be taken to optimize the patient's own blood volume, minimize the patient's blood loss and to harness and optimize physiological tolerance of anemia…". A comprehensive PBM program includes a preoperative anemia clinic to facilitate these goals. At our institution, 21% of surgical patients are anemic prior to their elective surgery and these patients consume approximately 67% of our transfused operating room blood. Our aim was to reduce red blood cell transfusions in elective orthopedic surgical patients by 25% and decrease hospital LOS through the implementation of a preoperative anemia clinic. Methods: After enlisting the support of hospital leadership, a preoperative anemia clinic referral/consult order was added the electronic medical record. Appropriate patients for referral were undergoing elective orthopedic surgery and had anemia defined as a Hgb <11.0 g/dl. Additional non-anemic patients with extenuating circumstances such as religious objection to transfusion were also referred. Every effort was made to see patients at least 2 weeks prior to the date of scheduled surgery or within 48 hours if the referral was not placed that far in advance. Work-up of anemia was individualized based on a patient's laboratory abnormality and medical profile. Interventions were targeted at treating the underlying cause of anemia and included but were not limited to parenteral iron, erythropoietin receptor agonists, and vitamin B12 injections. The primary measures assessed were the average LOS from day of surgery to discharge and the number of red blood cell units transfused during that stay. Findings: Early data since implementing our preoperative anemia clinic has demonstrated a reduction in LOS from 5.5 days for anemic patients undergoing elective surgery without a referral versus 3.5 days for those with a referral. A relative decrease in LOS of 36%. Reductions in hospital LOS were observed across the spectrum of all elective surgical procedures. The overall red blood cell transfusion rate in patients without referral versus with referral was 1.5% and 1.2% respectively; and of those requiring a transfusion, the mean red blood cell units transfused in the perioperative period was 2.31 units versus 1.19 units, resulting in a relative reduction of 48%. Additionally, 2 patients were diagnosed with a gastric ulcer and 2 patients with multiple myeloma during work-up and referred appropriately for treatment. Discussion: Expansion of the PBM program at our institution to include a preoperative anemia clinic has led to significant reductions in both red blood cell transfusions and hospital LOS in elective orthopedic surgical patients. Early results indicate a near doubling of our goal of a 25% reduction in red blood cells transfused. This has positively impacted our patients and led to both direct and indirect financial savings at our institution. Given the initial success, we hope to expand our preoperative anemia clinic to include all surgical specialties and streamline workflow. To facilitate growth additional staffing will be required. We have created patient education videos about the benefits of correcting their anemia prior to an elective surgery and hope to further engage primary care practitioners to refer patients earlier in their surgical evaluation. We conclude that the creation of a preoperative anemia clinic at our institution is a valuable resource and has led to a decreased use of red blood cell transfusions, a decreased average hospital LOS, improved patient safety and considerable financial savings. Figure. Figure. Disclosures No relevant conflicts of interest to declare.

Patient blood management knowledge and practice among clinicians from seven European university hospitals: a multicentre survey

Vox Sanguinis ◽  
2017 ◽  
Vol 113 (1) ◽  
pp. 60-71 ◽  
Author(s):  
P. M. Manzini ◽  
A. M. Dall'Omo ◽  
S. D'Antico ◽  
A. Valfrè ◽  
K. Pendry ◽  
...  
Keyword(s):  
Patient Blood Management ◽  
Blood Management ◽  
University Hospitals ◽  
Management Knowledge ◽  
Knowledge And Practice ◽  
European University

Effectiveness of a patient blood management protocol on reduction of allogeneic red blood cell transfusions in orthopedic surgery

2019 ◽  
Vol 152 (3) ◽  
pp. 90-97
Author(s):  
Mauricio Polanco-García ◽  
Ana María Capielo ◽  
Xavier Miret ◽  
Antonio Chamero ◽  
Julio Sainz ◽  
...  
Keyword(s):  
Blood Cell ◽  
Red Blood Cell ◽  
Orthopedic Surgery ◽  
Patient Blood Management ◽  
Blood Management ◽  
Management Protocol ◽  
Red Blood Cell Transfusions

Patient Blood Management is Associated With a Substantial Reduction of Red Blood Cell Utilization and Safe for Patientʼs Outcome

2016 ◽  
Vol 264 (2) ◽  
pp. 203-211 ◽  
Author(s):  
Patrick Meybohm ◽  
Eva Herrmann ◽  
Andrea U. Steinbicker ◽  
Maria Wittmann ◽  
Matthias Gruenewald ◽  
...  
Keyword(s):  
Blood Cell ◽  
Red Blood Cell ◽  
Substantial Reduction ◽  
Patient Blood Management ◽  
Blood Management
Sign in / Sign up

Export Citation Format

Share Document